Navigation Links
Bayer HealthCare to Sponsor World Federation of Hemophilia Global Training Program and Donate Kogenate® FS, Antihemophilic Factor (Recombinant), Commercially Valued At More Than $7 Million
Date:4/28/2011

ips have been awarded to hematologists, nurses, physiotherapists, laboratory scientists, orthopedic surgeons and dentists.  Since the program's founding, 400 fellows from 80 countries have received training.  Of note, more than 70% of fellows who have received training continue their career in hemophilia care.  

"More than 40 years after its founding, the IHTC program continues to improve the education of health care professionals who are dedicated to treating people with hemophilia," said Hansjoerg Duerr, Ph.D., Vice President, Specialty Medicine, Bayer HealthCare Pharmaceuticals.  "It is Bayer's privilege to sponsor an initiative of such great importance and also to make such a significant donation of Kogenate FS."

About Hemophilia A

Hemophilia A, also known as factor VIII deficiency or classic hemophilia, is largely an inherited bleeding disorder in which one of the proteins needed to form blood clots in the body is missing or reduced. Hemophilia A is the most common type of hemophilia and is characterized by prolonged or spontaneous bleeding, especially into the muscles, joints, or internal organs. Approximately 400,000 people around the world have hemophilia.

About Kogenate® FS/KOGENATE® Bayer

Indications and Usage

Kogenate® FS, antihemophilic factor (recombinant) /KOGENATE® Bayer (recombinant coagulation Factor VIII [octocog alfa]) is a recombinant factor VIII treatment indicated for the control and prevention of bleeding episodes and perioperative management in adults and children (0-16 years) with hemophilia A. Kogenate® FS/KOGENATE® Bayer is also indicated for routine prophylaxis to reduce the frequency of bleeding episodes and the risk of joint damage in children with hemophilia A with no preexisting joint damage.

Important Safety Information

The most serious adverse reactions are systemic hypersensitivity reactions and th
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
5. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
6. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
9. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 21, 2014   BioNano Genomics , the ... research centers to purchase an Irys™ System . ... Cancer Institute (NCI), NIH Intramural Sequencing Center (NISC) and ... obtaining a comprehensive view of a genome was ... does not deliver the scalability or reliability to ...
(Date:10/22/2014)... ANAHEIM, Calif. , Oct. 21, 2014 Influenza ... with flu-associated deaths in the United States ... influenza viruses are thought to spread is from person to ... Ebola has a serve way of death, but kills ... of Ebola is also done by human fluids including sweat, ...
(Date:10/22/2014)... 22, 2014 Sanomedics International Holdings, Inc. (OTCQB: ... Global Research & Data Services, demand for thermometers is ... through 2018, as demand for more accurate digital thermometers ... the world,s largest market for thermometers, and one of ... Sanomedics International Holdings, Inc. Sanomedics International Holdings ...
Breaking Medicine Technology:BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 3WholeHealth Products is proud to be releasing its Influenza A and B combo test, on the heels of the announcing of its phase 2 completion of the Rapid Ebola Test 2Sanomedics International Holdings Analyst Report: Taking Some Heat by BrokerBank Securities, Inc. 2
(Date:10/25/2014)... 25, 2014 More than 50 Family ... Reception on Monday at the home of Jim and ... from guest speaker Dr. Winifred Lender on finding the ... Lender, a Santa Barbara psychologist, author and Noozhawk columnist, ... of living in the digital age. Our digital reality ...
(Date:10/25/2014)... Wisconsin (PRWEB) October 25, 2014 QueenBeeTickets.com ... for a great selection at affordable prices. Bob Seger ... Center Huntington Center and Nationwide Arena are going on ... , Click Here to browse the selection ... Band at QueenBeeTickets.com. , The famous singer is touring ...
(Date:10/25/2014)... supply to an arm or a leg before heart surgery ... to a new study. "During heart surgery we ... be able to operate on it. After some time without ... energy because it doesn,t get oxygen. When we shut off ... arm or a leg, the body prepares for an upcoming ...
(Date:10/25/2014)... 23, 2014 (HealthDay News) -- Current osteoporosis screening ... postmenopausal women at risk for osteoporosis-related fractures, a ... prevent fractures, we need tools that help us ... so that we can target these at-risk people ... professor of medicine in the division of general ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 On October ... Minds featuring skin diseases both fictional and real. ... (CEHMDF), a nonprofit organization committed to advocacy and philanthropy ... CBS will take the opportunity to impart truth and ... , There are many misconceptions about Morgellons ...
Breaking Medicine News(10 mins):Health News:Finding Balance between the Real & Digital World Topic of Family Service Agency Reception 2Health News:Finding Balance between the Real & Digital World Topic of Family Service Agency Reception 3Health News:Finding Balance between the Real & Digital World Topic of Family Service Agency Reception 4Health News:QueenBeeTickets.com Features Bob Seger & The Silver Bullet Band Tickets for Charleston Civic Center, Huntington Center, and Nationwide Arena at Reduced Prices 2Health News:Brief Interruption of Blood Supply to Limb Might Aid Heart Surgery: Study 2Health News:Osteoporosis Screening Guidelines May Miss Younger Women at Risk 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3
... International AIDS Society (IAS), conveners of the International AIDS ... People Living with HIV (GNP+), the International Council of ... with HIV/AIDS (ICW) and the United Nations Joint Programme ... civil society and local partners for the XIX International ...
... the effectiveness of a broad selection of popular slimming ... found no evidence that any of them facilitate weight ... today (Monday) at the International Congress on Obesity in ... than the fake supplements they were compared with. ...
... of nearly 150 randomized controlled trials on children all ... 60 percent of the studies either failed to take steps ... describe those measures. A report of the team,s findings ... experimental trials sponsored by pharmaceutical or medical-device makers, along with ...
... HealthDay Reporter , FRIDAY, July 9 (HealthDay News) -- ... the United States in recent years, are exposing patients to ... of its kind. , , But experts really don,t know ... long-term effects will be, according to new research published online ...
... 9, 2010) -- At the 52nd meeting of the ... from July 18 - 22, 2010 in Philadelphia, PA, ... to share the latest developments in medical imaging and ... discuss many of the ethical and regulatory issues that ...
... , FRIDAY, July 9 (HealthDay News) -- Researchers report ... addiction in rats and may have the same effect in ... of the journal Nature , are preliminary, but they ... of anti-addiction medications," said study senior author Paul J. Kenny, ...
Cached Medicine News:Health News:Civil society and local partners for XIX International AIDS Conference (AIDS 2012) announced 2Health News:Civil society and local partners for XIX International AIDS Conference (AIDS 2012) announced 3Health News:New research finds no evidence that popular slimming supplements facilitate weight loss 2Health News:New research finds no evidence that popular slimming supplements facilitate weight loss 3Health News:Pediatric clinical studies appear prone to bias, Hopkins review shows 2Health News:Pediatric clinical studies appear prone to bias, Hopkins review shows 3Health News:Cumulative Radiation Doses Seen in Cardiac Imaging 2Health News:Cumulative Radiation Doses Seen in Cardiac Imaging 3Health News:Preliminary highlights of the AAPM 52nd Annual Meeting, Philadelphia, Pa., July 18-22, 2010 2Health News:Preliminary highlights of the AAPM 52nd Annual Meeting, Philadelphia, Pa., July 18-22, 2010 3Health News:Preliminary highlights of the AAPM 52nd Annual Meeting, Philadelphia, Pa., July 18-22, 2010 4Health News:Preliminary highlights of the AAPM 52nd Annual Meeting, Philadelphia, Pa., July 18-22, 2010 5Health News:Preliminary highlights of the AAPM 52nd Annual Meeting, Philadelphia, Pa., July 18-22, 2010 6Health News:Rat Study Sheds Light on Cocaine Addiction 2
TG (Ab) RIA Thyroid Function 014-HD 27.1 Thyroglobulin...
Free T4 EIA Thyroid Function 025-BC-1008...
... immunoassay (EIA) test kit is to be ... estriol in human serum during the second ... is an enzyme immunoassay, which is based ... procedure, estriol is conjugated to the enzyme,horseradish ...
... The procedure follows the basic principle of ... competition between an unlabeled antigen and an ... sites of a specific antiserum . The ... estrone) bound to the antibody is inversely ...
Medicine Products: